Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors
NCT00888043
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
CNTO 95 and avastin
Sponsor
Herbert Hurwitz, MD
Collaborators
[object Object]
[object Object]